Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Masimo

Apple Watch ban isn't stopping third-party sales — but Apple can't tell you that

Apple can't sell you an Apple Watch 9 or Apple Watch Ultra 2 due to an impending ban, but while you can look in other stores for one, Apple's own staff isn't allowed to mention this.

Tom’s Guide

Apple Watch ban could be avoided if only Apple was willing to talk, owner of the tech at the heart of a long-running patent battle hints — but its CEO isn't optimistic

The CEO of Masimo, the company that owns a patent Apple is accused of infringing, says he'd be willing to discuss a settlement — but Apple seems uninterested.

iMore

Masimo warns Apple that a swift software update is not enough to allow banned watches back on the market

Apple is furiously working on a software upgrade for the Series 9 and Utra 2 watches that were withdrawn from sale following a patent row

Advnture

From analysis to the latest developments in health,
read the most diverse news in one place.

Apple Races Against Time to Avoid Ban of Watch Series 9 and Ultra 2: What We Know

You can still buy Apple's smartwatches with third-party retailers

Latin Times

Apple to Halt Sales of Watch Series 9 and Ultra 2 in the U.S. Due to Patent Dispute

Apple on Monday said it would pause sales of its Watch Series 9 and Ultra 2 in the U.S. due to an ongoing patent dispute. The patents in question cover the blood oxygen feature in the watches, and belong to medical technology company Masimo. Apple itself said it would halt…

AnandTech

Patent row forces Apple to halt sales of Apple Watch Series 9 and Ultra 2

Authorities say Apple's SpO2 tracking violates a rival's patent

Advnture

Apple Watch ban — how claims of stolen tech forced Apple to pull Apple Watch 9 and Apple Watch Ultra 2

Apple will halt sales of the popular Apple Watch Series 9 and Ultra 2 by week's end. Here's what you need to know.

Tom’s Guide

Read news from The Economist, FT, and more,
with one subscription

Apple stops selling latest Apple Watch after losing patent case

Apple said sales of its Series 9 and Ultra 2 smartwatches would be halted this week after it lost a case over whether the tech giant stole a patented blood oxygen feature from another company.

WEKU

Apple Pauses US Sale Of Latest Watch Models Over Patent Clash

Apple on Monday said it will stop selling some of its smartwatch models in the United States while it fights a patent battle over technology for detecting blood oxygen levels.

International Business Times

Apple halting Apple Watch 9 and Apple Watch Ultra 2 sales this week over patent dispute — what it means for you

Following an ITC patent dispute ruling, the Apple Watch Series 9 and Apple Watch Ultra 2 are being pulled from the Apple Store. The ban begins on December 21 for Apple.com.

Tom’s Guide

Apple Watch Ultra 2 and Series 9 sales ban: all your questions, answered

Apple Watch Series 9 and Ultra 2 are about to be taken off shelves - but can you still get one in time for the holidays?

TechRadar

Apple is about to stop selling the Apple Watch Series 9 and Ultra 2 – here are all the details

It follows a patent dispute about the medical sensors.

TechRadar

Biden must decide whether patent-infringing Apple watches can be imported into the U.S. from China by Christmas–but Congress could neuter America’s ability to protect its IP altogether

The U.S. International Trade Commission (ITC) recently issued an order that could prohibit imports of some Apple Watch products.

Fortune

Apple Watch faces US ban over patent dispute — what you need to know

A patent dispute over the Apple Watch's pulse oximeter tech may lead to an outright ban in the US.

Tom’s Guide

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Masimo Surges After Winning A Potential $100 Million Battle Against Apple

Masimo could take a bite out of Apple's sales, an analyst said Friday as MASI stock surged after winning a patent battle.

Investors Business Daily

Masimo Crashes To Four-Year Low; Why It Could Take 'Months To Regain Footing'

It could take Masimo months to regain its footing, an analyst said Tuesday as investors hammered MASI stock on a massive sales miss.

Tom’s Guide

I test headphones for a living and these are the wireless earbuds I'm most excited for in 2023

My favorite wireless earbuds from last year are about to be upstaged by two new models from Denon using the same sound tech for the ultimate personalized listening experience.

TechRadar

Denon PerL earbuds offer Per(sonalized) L(istening) with new proprietary tech

The Denon PerL Pro and Denon PerL use proprietary tech to analyse the user's ear for a tailored listening experience'.

Get all your
news in one place.

100’s of premium titles.
One news app.

What Hi-Fi?

Denon's new wireless earbuds are Bose and Sony rivals that can measure your hearing

The new PerL wireless buds challenge the Sony and Bose class-leaders with strong codec support, battery life, ANC and unique tech for a bespoke audio profile

iMore

$1.8 billion Apple Watch lawsuit crumbles as mistrial called

A lawsuit alleging Apple stole trade secrets for future Apple Watch sensors has been called as a mistrial after jurors failed to reach a verdict.

Fortune

Shareholder activism's rise comes with more failures

Experts say it's not a sign of an ESG backlash.

Investors Business Daily

How Masimo Is Taking On Electronics Giant Apple — And Winning

Masimo stock surged Wednesday after a U.S. judge ruled Apple infringed on two patents protecting Masimo's blood-oxygen-reading technology.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2022

Upgrades

Benzinga

Masimo's (MASI) Q2 Earnings Surpass Estimates, Margins Down

Masimo Corporation (NASDAQ: MASI) delivered adjusted earnings per share (ETF:EPS) of $1.35 in the second quarter of 2022, up 43.6% year over year. The figure surpassed the Zacks Consensus Estimate by 13.5%.

Benzinga

Masimo's Return on Invested Capital Insights

According to Benzinga Pro, during Q1, Masimo (NASDAQ:MASI) earned $46.59 million, a 31.74% increase from the preceding quarter. Masimo's sales decreased to $304.24 million, a 7.12% change since Q4.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Lawsuit

10,414 stories

Intellectual Property

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.